Evidence supporting the use of: Vitamin E (vitamin E acetate)
For the health condition: Diabetic Retinopathy

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Vitamin E (including vitamin E acetate) has been investigated for its potential role in supporting or treating diabetic retinopathy due to its antioxidant properties. Oxidative stress is considered a contributing factor in the pathogenesis of diabetic retinopathy, and antioxidants like vitamin E have been hypothesized to help mitigate retinal damage. Several small clinical studies and animal experiments have examined the efficacy of vitamin E supplementation in patients with diabetes or diabetic retinopathy. Some of these studies have shown modest improvements in biochemical markers of oxidative stress and retinal function. For instance, a limited number of short-term trials have reported that vitamin E may slow the progression of early diabetic retinal changes or improve retinal blood flow. However, the overall quality of evidence is low, with most human studies being small, of short duration, or lacking robust clinical endpoints (such as prevention of vision loss). Systematic reviews and meta-analyses generally conclude that there is insufficient high-quality evidence to recommend vitamin E as a standard therapy for diabetic retinopathy. Major clinical guidelines do not currently endorse vitamin E supplementation for this indication. In summary, while there is a plausible biological rationale and some preliminary scientific data, the evidence is not strong or consistent enough to firmly support vitamin E’s use for diabetic retinopathy, and more research is needed to determine its true efficacy and safety in this context.

More about Vitamin E (vitamin E acetate)
More about Diabetic Retinopathy

Products containing Vitamin E (vitamin E acetate)

We currently have no products on Vitabase that contain this ingredient.